Surgery Doctors in Grosse Pointe, MI Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

Dr. Dharti Sheth, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 468 Cadieux Rd Fl 2, Grosse Pointe, MI 48230 Phone: 313-473-6900    Fax: 586-771-8901

Mr. Norman Alexander Bolz, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 19229 Mack Ave, Suite 34, Grosse Pointe, MI 48236 Phone: 313-343-0209    Fax: 313-343-0427

Michael C. Coello, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 16815 E Jefferson Ave Ste 240, Grosse Pointe, MI 48230 Phone: 313-473-4690

Dr. Krikor Garo Arman Ii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 16815 E Jefferson Ave, Grosse Pointe, MI 48230 Phone: 313-473-4690

Charles J Shanley, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 16815 E Jefferson Ave Ste 240, Grosse Pointe, MI 48230 Phone: 313-473-4690    Fax: 248-551-3023

Dr. Megan Hutchins D'john, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 16815 E Jefferson Ave Ste 240, Grosse Pointe, MI 48230 Phone: 313-473-4690

John M Hartzell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 468 Cadieux Rd, Grosse Pointe, MI 48230 Phone: 313-473-1968

News Archive

Biomedical use of gold nanotubes demonstrated in mouse model of human cancer

Scientists have shown that gold nanotubes have many applications in fighting cancer: internal nanoprobes for high-resolution imaging; drug delivery vehicles; and agents for destroying cancer cells.

Migraine attacks may actively protect and repair the brain from oxidative stress

A new perspective article highlights a compelling theory about migraine attacks: that they are an integrated mechanism by which the brain protects and repairs itself. Recent insightful findings and potential ways to use them to help migraine sufferers are published in Headache.

Replikin Counts of H5N1 and H1N1 strains on the rise

The most recent BioRadar analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain.

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that a presentation of results from its Phase 3 clinical trial of Lymphoseek (technetium 99m tilmanocept) Injection in patients with head and neck squamous cell carcinoma received the 1st Investigator Award at the 2nd InternationaI Symposium on Thoracic and Upper Aerodigestive Malignancies.

Open nephron-sparing surgery remains the most desirable for the patients

Urologists often view less-invasive surgery techniques as more desirable for the patient, but in a study of open nephron-sparing surgeries (NSS) from 1985 to 2001 at Mayo Clinic, researchers found that the "gold standard" of open surgery for kidney tumors should remain the first choice for many patients. The study appears online today in The Journal of Urology.

Read more Medical News

› Verified 3 days ago